查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004808

醫院罩衣市場：依產品類型、布料類型、最終用戶及通路分類－2026-2032年全球市場預測

Hospital Gowns Market by Product Type, Fabric Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫院病號罩衣市場價值將達到 68 億美元，到 2026 年將成長至 77.1 億美元，到 2032 年將達到 161.5 億美元，複合年成長率為 13.15%。

主要市場統計數據
基準年 2025 68億美元
預計年份：2026年 77.1億美元
預測年份 2032 161.5億美元
複合年成長率 (%) 13.15%

病人服裝的策略概述重點介紹了設計、臨床重點、採購慣例和供應鏈韌性如何改變醫院罩衣的決策。

患者服裝處於臨床護理、患者體驗和營運物流的交匯點。其設計和採購政策既體現了更廣泛的醫療保健系統優先事項，也同時影響實際的工作流程。醫院罩衣，過去被視為普通的消耗品，如今已成為感染控制、提升病患尊嚴和成本控制的戰略資產。這種轉變引發了臨床醫生、供應鏈負責人、設計師和採購專家之間的熱烈討論，他們必須在臨床性能要求與可生產性和成本限制之間取得平衡。

受臨床需求、永續性優先事項、製造技術進步和靈活分銷模式的驅動，患者服裝領域模式轉移，這正在改變供應商之間的競爭格局。

在醫院罩衣領域，由於臨床需求、永續性要求和製造技術創新三者融合，一場變革正在發生。設計不再局限於簡單的遮蓋身體，而是融入了尊嚴、便利性和模組化等元素，以打造更適合各種臨床操作和患者活動需求的服裝。製造商也積極響應，採用可調節的扣件、符合人體工學的版型以及兼顧透氣性和防護性能的高性能布料。

2025 年關稅調整將如何重塑籌資策略、供應鏈佈局和採購慣例，以增強應對貿易相關中斷的韌性。

預計於2025年生效的政策和貿易發展將為醫院罩衣產業的籌資策略、供應商選擇和成本建模帶來新的考量。關稅調整將改變不同地區生產經濟的比較方式，促使各機構重新評估先前僅以單價為最佳化目標的籌資策略。當某一地區的供應成本上升時，採購方通常會重新評估包括運費、海關手續費和庫存緩衝在內的總到岸成本，從而導致訂貨週期和合約承諾的調整。

基於細分市場的詳細洞察，將產品成分、布料選擇、臨床環境和分銷通路與營運績效和採購結果聯繫起來。

產品細分會影響臨床團隊對產品效用的認知，以及採購部門對總成本和物流的評估。在考慮產品類型時，封閉式和開放式設計在患者保護和操作功能方面都至關重要。封閉式防護罩衣可細分為魔鬼氈和繫帶兩種款式，每種款式在穿戴速度、可調節性和可重複使用性方面各有優劣。相較之下，開放式防護衣包括雙側開口和單側開口兩種類型，優先考慮操作時的快速便捷性和患者轉運的便利性，這會影響庫存配置和洗滌能力。

美洲、歐洲、中東和非洲以及亞太地區在供應、法規和採購方面的差異決定了供應商的選擇和營運重點。

區域趨勢造就了獨特的需求模式和供應面應對措施，進而影響產品供應、法規預期和採購重點。在美洲，採購決策往往受到大規模綜合醫療保健系統的影響，這些系統優先考慮標準化、供應商整合和總體擁有成本 (TCO) 分析，包括洗衣和廢棄物管理方面的考慮。儘管區域供應商和近岸製造商在前置作業時間和遵守嚴格的感染控制準則方面競爭，但買方更重視可預測的供應和服務水準協議 (SLA)。

受布料技術、緊固系統、供應鏈整合和永續發展措施等方面的創新驅動，供應商之間的競爭正在重塑買賣雙方的關係。

隨著供應商圍繞產品差異化、永續發展措施和供應鏈應對力調整策略，醫院病號罩衣市場的競爭日益激烈。大型製造商憑藉其規模、檢驗的品管系統以及與醫療機構的長期合作關係，繼續保持著市場影響力；同時，中小型專業公司也透過提供布料科學、固定裝置和模組化設計等創新技術，不斷提升患者的舒適度和醫護人員的使用便利性，從而擴大市場佔有率。

為製造商、醫療保健系統和採購團隊提供切實可行的策略建議，以協調產品創新、採購韌性和永續性實施。

產業領導企業應採取多管齊下的方法，整合臨床洞察、採購規範和營運柔軟性，以確保強大的競爭優勢。首先，應優先考慮與已記錄的臨床工作流程和患者體驗目標相符的產品系列，確保透過臨床醫生測試和洗滌評估檢驗閉合方式、布料配方和結構選擇。在產品開發的早期階段就讓臨床醫生和感染控制專家參與其中，可以降低推廣應用的阻力，並提高長期採用率。

以實踐者為中心的穩健研究途徑，整合臨床指南、供應商評估、相關人員訪談和情境分析，以產生可操作的見解。

支持這些發現的研究透過將對臨床指南、生產實踐和供應鏈框架的系統性回顧與一手訪談和產品評估相結合，確保了其實際應用性。在整合證據時，優先考慮同儕審查文獻、相關衛生監管機構標準和公開的監管文件，並將其與來自醫療服務提供者和供應商的營運數據進行交叉核對，以檢驗假設並揭示實際應用中的限制因素。

整合作為結論：這突顯了整合的產品設計、採購情報和供應鏈適應如何決定韌性和以病人為中心的結果。

醫院罩衣不再只是背景耗材，而是改善病患體驗、加強感染控制和提升供應鏈韌性的實際有效手段。緊固件和布料的產品創新，加上對永續性的考量以及不斷變化的貿易環境，都要求臨床醫生、採購負責人和供應商之間進行更緊密的合作。在實踐中，這意味著要使產品選擇與臨床工作流程相匹配，投資於生命週期評估以確定可重複使用和一次性使用的產品，並實現採購來源多元化以降低地緣政治和關稅風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫院病號罩衣市場：依產品類型分類

  • 封閉式後背打字機
    • 魔鬼氈
    • 繩扣
  • 無背式
    • 兩側均有開口
    • 單側開啟

第9章：依材料分類的醫院病號罩衣市場

  • 混合
    • 棉/聚酯混紡
    • 聚丙烯混合物
  • 棉布
  • 聚酯纖維

第10章：醫院病號罩衣市場：依最終用戶分類

  • 門診部
  • 診所
    • 門診部
    • 私人診所
  • 醫院

第11章：醫院病號罩衣市場：依通路分類

  • 離線
  • 線上

第12章：醫院病號罩衣市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：醫院病號罩衣市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：醫院病號罩衣市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫院病號罩衣市場

第16章：中國醫院病號罩衣市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Angelica Corporation
  • Cardinal Health, Inc.
  • Cintas Corporation
  • FullStar
  • Gownies
  • Halyard Health
  • Lantec Medical Group
  • Linde Healthcare
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Owens & Minor, Inc.
  • Prima International
  • Propper Medical
  • Standard Textile Co., Inc.
  • STERIS plc
  • SURGITOOLS
  • Unitex
Product Code: MRR-742BD517F7C6

The Hospital Gowns Market was valued at USD 6.80 billion in 2025 and is projected to grow to USD 7.71 billion in 2026, with a CAGR of 13.15%, reaching USD 16.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.80 billion
Estimated Year [2026] USD 7.71 billion
Forecast Year [2032] USD 16.15 billion
CAGR (%) 13.15%

A strategic overview of patient apparel highlighting how design, clinical priorities, procurement practices, and supply chain resilience are reshaping hospital gown decision-making

Patient apparel sits at the intersection of clinical care, patient experience, and operational logistics; its design and procurement reflect broader health-system priorities while also influencing frontline workflows. Historically treated as a commodity, hospital gowns have emerged as a strategic asset for infection prevention, dignity-preserving design, and cost management. This shift has elevated conversations among clinicians, supply chain leaders, designers, and procurement specialists who must reconcile clinical performance requirements with manufacturability and cost constraints.

In addition, material science advances and heightened regulatory scrutiny have changed expectations for fabric performance, disposability, and laundering protocols. Healthcare organizations are increasingly attentive to how gown attributes-closure type, fabric blend, and construction-impact patient coverage, clinician access during procedures, and laundry throughput. These operational considerations feed directly into supplier selection, contract terms, and inventory strategies.

Finally, global supply chain disruptions, evolving tariff landscapes, and shifting distribution models have exposed vulnerabilities and opportunities. Organizations now prioritize supplier diversity, nearshoring where feasible, and more flexible procurement models that balance direct relationships with distributors and online retail channels. Together, these drivers create a complex decision environment where clinical, operational, and commercial tensions must be navigated with clarity and evidence-based planning.

Evolving patient apparel paradigms driven by clinical needs, sustainability priorities, manufacturing advances, and flexible distribution models transforming supplier competition

The hospital gown landscape is experiencing transformative shifts driven by a convergence of clinical demands, sustainability imperatives, and manufacturing innovation. Design has moved beyond basic coverage to incorporate dignity, accessibility, and modularity, enabling products that better align with diverse clinical procedures and patient mobility needs. Manufacturers are responding by integrating adjustable closures, ergonomic patterns, and performance fabrics that balance breathability with barrier protection.

Concurrently, sustainability considerations are accelerating adoption of alternative fabric blends and lifecycle-aware procurement practices. Health systems are assessing the total cost of ownership for reusable versus disposable garments, factoring in laundering energy use, water consumption, and waste management. The result is a more nuanced supplier conversation that includes material provenance, recyclability, and reuse logistics alongside traditional performance metrics.

Technological and process innovations in manufacturing-such as automated cutting and seam sealing-are shortening lead times and improving consistency. These capabilities, when combined with more sophisticated distribution models that leverage direct sales, distributor partnerships, and online retail channels, enable faster response to demand spikes and localized preferences. In short, the industry is shifting from commodity-driven procurement toward a differentiated ecosystem where product attributes, sustainability commitments, and supply chain agility define competitive advantage.

How 2025 tariff adjustments are reshaping sourcing strategies, supply chain footprints, and procurement practices to build resilience against trade-related disruptions

Policy and trade developments set to take effect in 2025 introduce new considerations for procurement strategies, supplier selection, and cost modeling across the hospital gown space. Tariff adjustments can alter comparative production economics between regions, prompting organizations to re-evaluate sourcing strategies that were previously optimized for unit price alone. When supply-side costs rise in one geography, buyers often reassess total landed cost, including freight, customs processing, and inventory buffers, which in turn reshapes order cadence and contractual commitments.

Importantly, tariff changes influence not only where products are sourced but also how manufacturers structure their value chains. Some producers respond by relocating production, investing in local finishing operations, or reallocating high-value features across product families to manage duty implications. Buyers should therefore anticipate greater heterogeneity in supplier footprints and an expansion of nearshore capabilities that can mitigate exposure to sudden tariff shifts.

From an operational perspective, increased duties typically encourage deeper collaboration between procurement and logistics to optimize shipment consolidation, harmonize product specifications to reduce SKU proliferation, and design contingency plans that prioritize patient-facing items. For risk-averse healthcare systems, the preferred approach will likely combine diversified sourcing, strategic stockpiling of critical SKUs, and stronger contractual protections related to price adjustments and force majeure clauses. Ultimately, tariff dynamics in 2025 are a catalyst for more resilient, geographically aware sourcing strategies across the sector.

Deep segmentation-driven insights that link product configurations, fabric choices, clinical settings, and distribution pathways to operational performance and procurement outcomes

Product segmentation drives the way clinical teams perceive utility and how procurement evaluates total cost and logistics. When examining product type, distinctions between closed back designs and open back designs matter for both patient coverage and operational functionality. Closed back gowns are refined into hook and loop closures and tie back variants, each offering different trade-offs in donning speed, adjustability, and reprocessability. In contrast, open back solutions include dual open side and single open side constructions that prioritize rapid access for procedures and ease of patient transport, with implications for inventory mix and laundering throughput.

Fabric type further differentiates performance and lifecycle considerations: pure cotton delivers breathability and patient comfort, polyester emphasizes durability and quick-dry properties, and blend constructions-such as cotton polyester blends and polypropylene blends-seek to combine comfort, barrier protection, and cost efficiency. These choices affect laundering protocols, tensile strength after repeated cycles, and compatibility with barrier treatments or antimicrobial finishes.

End-user segmentation is equally pivotal in aligning product attributes with clinical workflows. Ambulatory care centers and hospitals present distinct throughput patterns and procedural needs, while clinics-whether outpatient or private-often prioritize ease of storage, rapid turnaround, and patient satisfaction. These divergences influence reorder frequency, preferred closure systems, and fabric durability.

Distribution channel selection completes the picture: direct sales relationships can facilitate custom specifications and volume commitments, distributors-operating through retailers and wholesalers-offer breadth and logistical reach, and online retail channels provide rapid access for low-volume or specialty items. Effective segmentation-aware strategies integrate product type, fabric composition, end-user context, and distribution model to optimize patient outcomes and operational efficiency.

Regional supply, regulatory, and procurement contrasts across the Americas, Europe Middle East & Africa, and Asia-Pacific that define sourcing choices and operational priorities

Regional dynamics create distinct demand profiles and supply-side responses that influence product availability, regulatory expectations, and procurement priorities. In the Americas, purchasing decisions are often shaped by large integrated health systems prioritizing standardization, supplier consolidation, and total cost of ownership analyses that include laundering and waste management considerations. Regional suppliers and nearshore manufacturers compete on lead times and compliance with stringent infection-control guidelines, while buyer expectations emphasize predictable supply and service-level agreements.

In Europe, Middle East & Africa, regulatory diversity and varying infrastructure maturity produce a wide array of procurement approaches. Some healthcare systems emphasize sustainability and reuse protocols tied to environmental targets, while others prioritize access and affordability. Local regulations around medical textiles, along with logistical constraints in certain countries, encourage flexible product lines and the use of both centralized and decentralized distribution models.

Across Asia-Pacific, manufacturing capacity and material innovation play a central role. The region's extensive textile industry supports a range of options from low-cost disposable solutions to higher-value reusable garments. Growing domestic demand, combined with export-oriented production, means that regional pricing pressure can be balanced by rapid innovation cycles and scalability. Buyers operating across multiple regions must therefore reconcile varying regulatory regimes, supplier capabilities, and logistical realities to maintain consistent standards of care and minimize supply disruptions.

Supplier competitive movements driven by innovation in fabric technology, closure systems, supply chain integration, and sustainability credentials reshaping buyer-supplier relationships

Competitive dynamics within the hospital gown ecosystem are intensifying as suppliers reposition around product differentiation, sustainability credentials, and supply chain responsiveness. Established manufacturers remain influential due to scale, validated quality systems, and long-standing relationships with health systems, but smaller and more specialized firms are gaining traction by offering niche innovations in fabric science, closure mechanisms, and modular designs that improve patient comfort and clinician access.

Strategic partnerships between textile innovators and medical device firms are accelerating the diffusion of performance treatments-such as hydrophobic coatings and reinforced seams-that enhance barrier protection without compromising comfort. At the same time, some manufacturers are investing in vertical integration to control finishing processes and reduce lead times, while others rely on distributor networks to achieve broader market reach.

Procurement offices and group purchasing organizations are increasingly influential, applying rigorous supplier performance metrics and sustainability criteria to selection decisions. This shift elevates the importance of traceability, compliance documentation, and lifecycle assessments. For suppliers, the path to growth includes demonstrating consistent quality, transparent supply chains, and the ability to support custom configurations or rapid volume adjustments in response to clinical demand.

Actionable strategic recommendations for manufacturers, health systems, and procurement teams to align product innovation, sourcing resilience, and sustainability execution

Industry leaders should adopt a multifaceted approach that merges clinical insight, procurement discipline, and operational flexibility to secure a durable competitive position. First, prioritize product portfolios that align with documented clinical workflows and patient experience goals, ensuring that closure types, fabric blends, and construction choices are validated through clinician trials and laundering assessments. Embedding clinicians and infection prevention specialists early in product development reduces the risk of adoption friction and improves long-term utilization.

Second, develop diversified sourcing strategies that combine strategic direct relationships with select manufacturers, broad distributor coverage for geographic reach, and curated online channels for specialty or urgent needs. Nearshoring and flexible manufacturing agreements can reduce exposure to tariff volatility and shipping disruptions, while contractual provisions should explicitly address supply continuity, quality standards, and price adjustment mechanisms.

Third, invest in sustainability assessment frameworks that quantify environmental impacts across product lifecycles and inform procurement decisions. Lifecycle thinking paired with total cost analyses will clarify when reusable solutions outperform disposables on clinical and environmental metrics.

Finally, enhance data-driven procurement by adopting SKU-level analytics, traceability systems, and performance scorecards that link supplier performance to clinical outcomes and operational KPIs. Combining these capabilities enables quicker, evidence-based decisions and supports continuous improvement across design, sourcing, and distribution.

A robust, practitioner-focused research approach integrating clinical guidelines, supplier assessments, stakeholder interviews, and scenario analyses to produce actionable insights

The research underpinning these insights combined a structured review of clinical guidelines, manufacturing practices, and supply chain frameworks with primary interviews and product evaluations to ensure practical applicability. Evidence synthesis prioritized peer-reviewed literature, standards from relevant health authorities, and publicly available regulatory documents, which were cross-referenced with operational data from providers and suppliers to validate assumptions and surface real-world constraints.

Primary engagement included interviews with clinical stakeholders, procurement leaders, textile engineers, and logistics professionals to capture diverse perspectives on performance trade-offs, laundering realities, and procurement levers. Product assessments evaluated design features such as closure systems and seam construction alongside fabric composition and durability under repeated reprocessing cycles. These assessments informed comparative analyses of product types and fabric blends across typical end-user contexts.

Analytical methods included scenario planning to test resilience against supply disruptions, sensitivity analyses around procurement levers such as lead time and order minimums, and qualitative coding of stakeholder interviews to extract common pain points and adoption facilitators. Together, these methods produced robust, practitioner-focused conclusions that reflect both technical performance and the operational realities of delivering care under constrained budgets and evolving regulatory expectations.

Concluding synthesis emphasizing how integrated product design, procurement intelligence, and supply chain adaptation will determine resilience and patient-centered outcomes

The hospital gown landscape is no longer a background commodity; it is an actionable lever for improving patient experience, enhancing infection control, and strengthening supply chain resilience. Product innovation in closures and fabrics, coupled with sustainability considerations and shifting trade dynamics, requires closer coordination among clinicians, procurement professionals, and suppliers. In practice, this means aligning product selection with clinical workflows, investing in lifecycle assessments to inform reusable versus disposable choices, and diversifying supply bases to mitigate geopolitical and tariff risks.

Operational leaders should view gown strategy as part of a broader clinical supply ecosystem, where SKU rationalization, supplier performance monitoring, and adaptive contracting reduce waste and improve service levels. For manufacturers, success will depend on the ability to demonstrate measurable benefits-whether through improved patient coverage, reduced laundering costs, or faster response to demand changes. For buyers, the emphasis should be on integrating clinical evidence with procurement analytics to prioritize purchases that deliver the greatest value across quality and cost dimensions.

Ultimately, organizations that proactively adapt to the evolving design, regulatory, and trade environment will be best positioned to balance patient dignity, clinician efficiency, and supply reliability in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hospital Gowns Market, by Product Type

  • 8.1. Closed Back
    • 8.1.1. Hook And Loop
    • 8.1.2. Tie Back
  • 8.2. Open Back
    • 8.2.1. Dual Open Side
    • 8.2.2. Single Open Side

9. Hospital Gowns Market, by Fabric Type

  • 9.1. Blend
    • 9.1.1. Cotton Polyester Blend
    • 9.1.2. Polypropylene Blend
  • 9.2. Cotton
  • 9.3. Polyester

10. Hospital Gowns Market, by End User

  • 10.1. Ambulatory Care Center
  • 10.2. Clinic
    • 10.2.1. Outpatient Clinic
    • 10.2.2. Private Clinic
  • 10.3. Hospital

11. Hospital Gowns Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Hospital Gowns Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hospital Gowns Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hospital Gowns Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hospital Gowns Market

16. China Hospital Gowns Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Angelica Corporation
  • 17.6. Cardinal Health, Inc.
  • 17.7. Cintas Corporation
  • 17.8. FullStar
  • 17.9. Gownies
  • 17.10. Halyard Health
  • 17.11. Lantec Medical Group
  • 17.12. Linde Healthcare
  • 17.13. Medline Industries, LP
  • 17.14. Molnlycke Health Care AB
  • 17.15. Owens & Minor, Inc.
  • 17.16. Prima International
  • 17.17. Propper Medical
  • 17.18. Standard Textile Co., Inc.
  • 17.19. STERIS plc
  • 17.20. SURGITOOLS
  • 17.21. Unitex

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOSPITAL GOWNS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOSPITAL GOWNS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOOK AND LOOP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOOK AND LOOP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOOK AND LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY TIE BACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY TIE BACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY TIE BACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY DUAL OPEN SIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY DUAL OPEN SIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY DUAL OPEN SIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY SINGLE OPEN SIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY SINGLE OPEN SIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY SINGLE OPEN SIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY BLEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY BLEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY BLEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON POLYESTER BLEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON POLYESTER BLEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON POLYESTER BLEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYPROPYLENE BLEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYPROPYLENE BLEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYPROPYLENE BLEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY AMBULATORY CARE CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY PRIVATE CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY PRIVATE CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY PRIVATE CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 150. GCC HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 151. GCC HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 153. GCC HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 155. GCC HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 177. G7 HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 178. G7 HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 180. G7 HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 182. G7 HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 186. NATO HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 187. NATO HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 189. NATO HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 191. NATO HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL HOSPITAL GOWNS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA HOSPITAL GOWNS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA HOSPITAL GOWNS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA HOSPITAL GOWNS MARKET SIZE, BY CLOSED BACK, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA HOSPITAL GOWNS MARKET SIZE, BY OPEN BACK, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA HOSPITAL GOWNS MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA HOSPITAL GOWNS MARKET SIZE, BY BLEND, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA HOSPITAL GOWNS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA HOSPITAL GOWNS MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA HOSPITAL GOWNS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)